News & Events
News
AngelMD Closes Syndicate Funding Round in Fibralign
AngelMD,an investment and networking platform connecting innovative medical startups, physicians, investors, and industry partners, today announced that it has completed a Syndicate funding round for Fibralign, Inc. Fibralign produces therapeutic medical devices that...
Fibralign Corporation Appoints Dimitris Dionysiou, Ph.D., M.D. as Chief Medical Officer
Fibralign Corporation, a developer of advanced therapeutic medical devices, announces the appointment of Dimitris Dionysiou, Ph.D., M.D. as its Chief Medical Officer. Dr. Dionysiou joins the Company during the clinical phase for its first product, the BioBridge®...
Study shows nanofiber scaffolds could treat lymphedema by rerouting lymphatic system around blockage
Researchers at the School of Medicine have developed a possible treatment for lymphedema, the severe swelling of an arm or leg that can occur when the lymph system is blocked. Using scaffolding composed of specially patterned collagen nanofibers, the researchers...
Conferences
Fibralign and its research collaborators have made over 50 presentations related to BioBridge and Nanoweave scientific findings at international leading medical research conferences over the previous two years.
While these conferences have largely paused during 2020 due to the pandemic, we will post upcoming presentations when these conferences return to schedule.
